|  | Group | ||
---|---|---|---|---|
Variables | All cases | HAdV | HAdV/RSV | HAdV/RSV |
Single infection | Dual infections | Multiple infections | ||
(n = 150) | (n = 49) | (n = 18) | (n = 23) | |
Age (years)a | 2.37 ± 2.89 | 3.68 ± 3.64 | 1.53 ± 2.41 | 1.20 ± 0.81 |
Male (%) | 105 (70 %) | 32 (65.3 %) | 12 (66.7 %) | 17 (73.9 %) |
Symptoms and signs | Â | Â | Â | Â |
Fever | 144 (96.0 %) | 48 (98.0 %) | 17 (94.4 %) | 23 (100 %) |
T max (°C) | 39.53 ± 0.68 | 39.73 ± 0.66 | 39.48 ± 0.53 | 39.62 ± 0.73 |
Duration of fever (days) | 15.31 ± 13.35 | 18.06 ± 18.85 | 14.18 ± 5.86 | 15.17 ± 7.25 |
Cough | 149 (99.3 %) | 49 (100 %) | 18 (100 %) | 23 (100 %) |
Rhinorrhea | 24 (16.0 %) | 8 (16.3 %) | 2 (11.1 %) | 4 (17.4 %) |
Wheezing | 90 (60.0 %) | 25 (51.0 %) | 14 (77.8 %) | 17 (73.9 %) |
Swelling of tonsils | 44 (29.3 %) | 18 (36.7 %) | 2 (11.1 %) | 3 (13.0 %) |
Rash | 15 (10.0 %) | 5 (10.2 %) | 7 (12.3 %) | 3 (6.8 %) |
Vomitting | 14 (9.3 %) | 5 (10.2 %) | 1 (5.6 %) | 4 (17.4 %) |
Diarrhea | 32 (21.3 %) | 11 (22.4 %) | 3 (16.7 %) | 7 (30.4 %) |
Conjunctivitis | 7 (4.7 %) | 2 (4.1 %) | 1 (5.6 %) | 0 (0 %) |
Dyspnea | 61 (40.7 %) | 18 (36.7 %) | 8 (44.4 %) | 12 (52.2 %) |
ICU admission | 17 (11.3 %) | 7 (14.3 %) | 2 (11.1 %) | 5 (21.7 %) |
Any underlying diseases | 22 (14.7 %) | 10 (20.4 %) | 2 (11.1 %) | 2 (8.7 %) |
Treatment | Â | Â | Â | Â |
Mechanical ventilation | 38 (25.3 %) | 13 (26.5 %) | 4 (22.2 %) | 8 (34.8 %) |
Coticosteriods | 122 (81.3 %) | 40 (81.6 %) | 13 (72.2 %) | 22 (95.7 %) |
Inhaled Intravenous | 74 (49.3 %) | 22 (44.9 %) | 8 (44.4 %) | 14 (60.9 %) |
Immunoglobulin | 34 (22.7 %) | 8 (16.3 %) | 1 (5.6 %) | 6 (26.1 %) |
Length of hospital stay (days) | 18.32 ± 11.31 | 16.19 ± 11.01 | 20.17 ± 10.22 | 20.52 ± 10.44 |
Laboratory findings | Â | Â | Â | Â |
WBC (×109/L) | 10.09 ± 4.61 | 9.34 ± 4.85 | 10.50 ± 3.79 | 9.86 ± 4.26 |
CRP (mg/L) | 31.64 ± 35.93 | 36.01 ± 39.67 | 36.78 ± 30.25 | 32.42 ± 43.52 |
AST, median (IQR) (U/L) | 33 (45–71.5) | 45 (34–81.8) | 38.5 (33–56.3) | 57 (33–83) |
ALT, median (IQR) (U/L) | 21 (16–36) | 18.1 (15–33) | 21 (18–36.5) | 22 (19–46) |
LDH, median (IQR) (U/L) | 360 (262.5-668.5) | 369.5 (285.7-899.5) | 326.5 (260–584.5) | 439 (288–747) |
CK, median (IQR) (U/L) | 83 (45–192) | 87.5 (46.8-264) | 84 (42.5-221.8) | 88 (38–137) |
HBDH, median (IQR) (U/L) | 274 (200.5-508.5) | 275 (203.3-562.3) | 258 (203–447.9) | 355 (221.5–524) |